Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

Our Cipla Health franchise grew by 16% with margins reaching closer to mid-teens for the quarter. Big brands of Cipla Health scaled further by posting double-digit growth in revenues,” it stated.

Cipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst ...

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its respiratory and cancer drugs in its key ...

NEW YORK, May 27, 2025 /PRNewswire/ -- Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its ...

NEW YORK, May 27, 2025 /PRNewswire/ -- Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its ...